A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

Clinical trial NCT06643260 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06643260
Sponsor: Can-Fite BioPharma
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2025-06-01
Primary completion: 2027-12-01
Enrollment: 705

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.